Llovet JM - Search Results

1

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Torrens L, Montironi C, Puigvehí M, Mesropian A, Leslie J, Haber PK, Maeda M, Balaseviciute U, Willoughby CE, Abril-Fornaguera J, Piqué-Gili M, Torres-Martín M, Peix J, Geh D, Ramon-Gil E, Saberi B, Friedman SL, Mann DA, Sia D, Llovet JM. Torrens L, et al. Among authors: llovet jm. Hepatology. 2021 Nov;74(5):2652-2669. doi: 10.1002/hep.32023. Epub 2021 Sep 27. Hepatology. 2021. PMID: 34157147 Free article.

2

Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.

Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Brú C, Navasa M, Ayuso MC, Solé M, Real MI, Vilana R, Rimola A, Visa J, Rodés J. Llovet JM, et al. Hepatology. 1998 Jun;27(6):1572-7. doi: 10.1002/hep.510270616. Hepatology. 1998. PMID: 9620329

3

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MC, Vilana R, Rodés J. Bruix J, et al. Among authors: llovet jm. Hepatology. 1998 Jun;27(6):1578-83. doi: 10.1002/hep.510270617. Hepatology. 1998. PMID: 9620330 Clinical Trial.

4

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 1999 Jan;29(1):62-7. doi: 10.1002/hep.510290145. Hepatology. 1999. PMID: 9862851 Clinical Trial.

5

Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Llovet JM, Brú C, Bruix J. Llovet JM, et al. Semin Liver Dis. 1999;19(3):329-38. doi: 10.1055/s-2007-1007122. Semin Liver Dis. 1999. PMID: 10518312

6

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatology. 1999 Dec;30(6):1434-40. doi: 10.1002/hep.510300629. Hepatology. 1999. PMID: 10573522

7

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma.

Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, Ayuso C, Vargas V, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 2000 Jan;31(1):54-8. doi: 10.1002/hep.510310111. Hepatology. 2000. PMID: 10613728 Clinical Trial.

8

Diagnosis and treatment of hepatocellular carcinoma.

Suarez Y, Sala M, Llovet JM, Bruix J. Suarez Y, et al. Among authors: llovet jm. Acta Gastroenterol Belg. 1999 Oct-Dec;62(4):410-4. Acta Gastroenterol Belg. 1999. PMID: 10692771 Review.

9

Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.

Llovet JM, Moitinho E, Sala M, Bataller R, Rodríguez-Iglesias P, Castells A, Fernández J, Planas R, Navasa M, Bruix J, Rodés J. Llovet JM, et al. J Hepatol. 2000 Sep;33(3):423-9. doi: 10.1016/s0168-8278(00)80278-0. J Hepatol. 2000. PMID: 11019998

10

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Solé M, Rodés J, Bruix J; Barcelona Clínic Liver Cancer (BCLC) Group. Llovet JM, et al. Hepatology. 2001 May;33(5):1124-9. doi: 10.1053/jhep.2001.24233. Hepatology. 2001. PMID: 11343240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters